Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04760223 · ClinicalTrials.gov registry record · NA
Reducing Stigma Towards Depression Among Adolescents
A NA study, sponsored by Research Foundation for Mental Hygiene.
- Completed
- Registry status
- NA
- Development phase
- 1,183
- Enrollment target
NCT04760223: Completed NA study, sponsored by Research Foundation for Mental Hygiene.
NCT04760223 is a NA study that has completed, run by Research Foundation for Mental Hygiene. The registered enrollment target is 1,183 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04760223, a NA study, has completed, sponsored by Research Foundation for Mental Hygiene.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,183 participants
- Enrollment target
Study Summary
The investigators conducted a randomized controlled study to test the utility of a brief video-based intervention to: 1) reduce stigma towards depression, and 2) increase treatment-seeking intentions among adolescents.
Primary Outcome
Level of stigma towards depression measured by the 9-item Depression Stigma Scale (DSS). This is a 9-item self report questionnaire to measure the personal stigma towards depression. It has 5-point Likert scale tanging from strongly disagree (1) and strongly agree (5). It had test-retest reliability of 0.71 and internal consistency of 0.76 (Griffiths KM et al. 2004)
Interventions
- BEHAVIORAL Video intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,183 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2021-02-01 |
| Phase | NA |
What the finished NCT04760223 record still lists
NCT04760223 is an interventional study that assigns participants to a tested intervention. Its 1,183 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% lower).
The record links to 0 conditions, and to 1 intervention - of which Video intervention is the first listed.
NCT04760223 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04760223 about?
NCT04760223 is a clinical study titled "Reducing Stigma Towards Depression Among Adolescents". The investigators conducted a randomized controlled study to test the utility of a brief video-based intervention to: 1) reduce stigma towards depression, and 2) increase treatment-seeking intentions among adolescents.
What is the current status of trial NCT04760223?
This trial is currently completed. It is a NA study. The enrollment target is 1,183 participants. The study started on 2021-01-01. Estimated completion is 2021-02-01.
What interventions are being tested in trial NCT04760223?
The interventions under investigation include: Video intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04760223?
This trial is sponsored by Research Foundation for Mental Hygiene, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04760223's enrollment target sits among peer trials
1,183 89th of 2000 higher than 1,912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07286058 · 1,182 participants · Phase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- NCT04293562 · 1,186 participants · Phase 3
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- NCT05580419 · 1,188 participants · NA
Impact of 4PCP on Practitioner and Patient Outcomes
- NCT06290869 · 1,188 participants · Phase 3
Tobacco Education and Lung Health Study (TEAL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI